Financhill
Back

Affimed NV 10K Form

Sell
23

AFMD
Affimed NV

Last Price:
2.67
Seasonality Move:
4.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AFMD News And Ratings

See the #1 stock for the next 7 days that we like better than AFMD

AFMD Financial Statistics

Sales & Book Value

Annual Sales: $8.96M
Cash Flow: $-13.18M
Price / Cash Flow: 0
Annual Sales: $1.17
Price / Book: 2.7

Profitability

EPS (TTM): -4.95460
Net Income (TTM): $-75.87M
Gross Margin: $0
Return on Equity: -158.94%
Return on Assets: -91.92%

Affimed NV Earnings Forecast

Key Affimed NV Financial Ratios

  • The Gross Profit Margin over the past 4 years for AFMD is 0.00%.
  • The Selling, General & Administrative Expenses for AFMD have been equal to 298.19% of Gross Profit Margin.
  • The Research & Development expenses have been 1,147.53% of Revenue.
  • The Interest Expense is -1.70% of Operating Income.
  • The Net Earning history of AFMD is -1,280.22% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 4 years.

Affimed NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AFMD
Website: affimed.com

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 1.93
Quick Ratio: 1.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AFMD Technical Analysis vs Fundamental Analysis

Sell
23
Affimed NV (AFMD) is a Sell

Is Affimed NV a Buy or a Sell?

  • Affimed NV stock is rated a Sell
    The current Affimed NV [AFMD] share price is $2.72. The Score for AFMD is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.